{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A+PROTEIN+level&page=57", "query": { "intervention": "A PROTEIN level", "page": 57 }, "page_size": 10 }, "pagination": { "page": 57, "page_size": 10, "total_count": 1386, "total_pages": 139, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A+PROTEIN+level&page=58&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A+PROTEIN+level&page=56&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T18:31:01.894Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01950819", "title": "Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "End Stage Renal Disease (ESRD)", "Chronic Kidney Disease (CKD)", "Hemodialysis", "Renal Replacement Therapy", "Renal Transplantation" ], "interventions": [ { "name": "Induction therapy", "type": "BIOLOGICAL" }, { "name": "Corticosteroids", "type": "DRUG" }, { "name": "EVR+rCNI", "type": "DRUG" }, { "name": "MPA+sCNI", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2037, "start_date": "2013-12-03", "completion_date": "2018-01-17", "has_results": true, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01950819" }, { "nct_id": "NCT03469492", "title": "Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hyperglycaemia (Diabetic)" ], "interventions": [ { "name": "Insulin", "type": "DRUG" }, { "name": "exercise", "type": "BEHAVIORAL" }, { "name": "Dietary counseling", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "DIETARY_SUPPLEMENT" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 8, "start_date": "2018-01-18", "completion_date": "2020-03-20", "has_results": true, "last_update_posted_date": "2024-02-05", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03469492" }, { "nct_id": "NCT02683369", "title": "Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Non-anemic Iron Deficiency" ], "interventions": [ { "name": "Blood Builder®/Iron Response®", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 23, "start_date": "2016-02", "completion_date": "2017-05", "has_results": false, "last_update_posted_date": "2019-08-16", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02683369" }, { "nct_id": "NCT00645879", "title": "Anaplerotic Therapy in Propionic Acidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Propionic Acidemia" ], "interventions": [ { "name": "ornithine alpha ketoglutarate", "type": "DRUG" }, { "name": "glutamine", "type": "DRUG" }, { "name": "disodium citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicola Longo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "5 Years to 12 Years" }, "enrollment_count": 3, "start_date": "2008-07", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2015-01-21", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645879" }, { "nct_id": "NCT05259696", "title": "Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Oncology", "Melanoma", "Ovarian Cancer", "NSCLC", "Non Small Cell Lung Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Cancer", "CRC", "Colon Cancer", "Breast Cancer", "Gastric Cancer", "EGJ", "Esophagogastric Junction Cancer", "Head and Neck Cancer", "Urothelial Cancer", "Bladder Cancer" ], "interventions": [ { "name": "E-602", "type": "BIOLOGICAL" }, { "name": "Cemiplimab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Palleon Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2022-02-11", "completion_date": "2024-10-24", "has_results": true, "last_update_posted_date": "2025-08-20", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 13, "location_summary": "La Jolla, California • Los Angeles, California • Stanford, California + 10 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05259696" }, { "nct_id": "NCT00536341", "title": "Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "lenalidomide", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SCRI Development Innovations, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2008-01", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2017-01-16", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 6, "location_summary": "Fort Myers, Florida • Orlando, Florida • Bethesda, Maryland + 2 more", "locations": [ { "city": "Fort Myers", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00536341" }, { "nct_id": "NCT00400686", "title": "Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anemia", "Multiple Myeloma", "Plasma Cell Neoplasm" ], "interventions": [ { "name": "epoetin alfa", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2003-09", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2018-02-22", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400686" }, { "nct_id": "NCT00438802", "title": "Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "Alefacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 23, "start_date": "2006-03", "completion_date": "2019-07-25", "has_results": true, "last_update_posted_date": "2019-08-13", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 3, "location_summary": "Duarte, California • Iowa City, Iowa • Rochester, Minnesota", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00438802" }, { "nct_id": "NCT05350553", "title": "Methylglyoxal Evaluation in Humans", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 2 Diabetes", "Neuropathy, Painful", "Chronic Low-back Pain", "Lumbar Disc Herniation" ], "interventions": [], "intervention_types": [], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 39, "start_date": "2022-05-02", "completion_date": "2025-04-01", "has_results": false, "last_update_posted_date": "2025-04-04", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05350553" }, { "nct_id": "NCT02467361", "title": "A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "BBI608", "type": "DRUG" }, { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 104, "start_date": "2015-08", "completion_date": "2021-01-29", "has_results": false, "last_update_posted_date": "2023-11-14", "last_synced_at": "2026-10-23T18:31:01.894Z", "location_count": 8, "location_summary": "Denver, Colorado • Atlanta, Georgia • Chicago, Illinois + 4 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02467361" } ] }